Last reviewed · How we verify
NCT05636878: EMPER
Creation and Evaluation of a Mobile Intervention Team in Perinatal Psychiatry (0-3 Years) in Meurthe-et-Moselle Sud
NA trial testing Mobile Intervention Team in Perinatal Psychiatry (EMPPer) in Abnormality in 4,260 participants. Currently enrolling.
1 December 2027
Quick facts
| Lead sponsor | Centre Psychothérapique de Nancy |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 4,260 |
| Start date | 18 August 2023 |
| Primary completion | 1 December 2027 |
| Estimated completion | 18 August 2028 |
| Sites | 1 location across France |
Drugs / interventions tested
- Mobile Intervention Team in Perinatal Psychiatry (EMPPer)
Conditions studied
- Abnormality — all drugs for Abnormality →
Sponsor
Centre Psychothérapique de Nancy
Who can join
Adults 1 Day to 3, any sex, with Abnormality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research system is a Mobile Perinatal Psychiatry Team (EMPPer), for children aged 0 to 3 and their parents. it facilitates access to psychiatric care by going to families who need it and who are in difficulty to ensure this process. This device, already deployed in a dozen French cities for several years, convinced the teams of its interest, without demonstrating its effectiveness by evaluation conducted according to research standards. The deployment of a Mobile Perinatal Psychiatry Team in a region not yet equipped (Meurthe-et-Moselle Sud) would therefore offer the opportunity to assess its effectiveness, The main objective of the research is to evaluate the effect of the EMPPer on the prevalence of abnormalities in the psychomotor development of children at the age of 2 years, in comparison with similar territories that do not benefit from it, and in comparison with the period preceding the establishment of the EMPPer in the targeted territory.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05636878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre Psychothérapique de Nancy trials
Trials by the same sponsor.
- NCT06532604 — Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder · NA · not yet recruiting
- NCT07499934 — Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study · NA · recruiting
- NCT06649552 — French Validation of Schizophrenia Proneness Instrument- Child Youth · NA · not yet recruiting
- NCT06361407 — Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia · NA · recruiting
- NCT06330467 — Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05636878 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Psychothérapique de Nancy
- Last refreshed: 8 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05636878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing